Personalized Gene Therapy Treatments for Cancer Market
According to Intent Market Research, the Personalized Gene Therapy Treatments for Cancer Market is expected to grow from USD 5.7 billion in 2024-e at a CAGR of 8.0% to touch USD 9.1 billion by 2030. The Personalized Gene Therapy Treatments for Cancer Market is dominated by key players such as, Gilead Sciences, Inc., Novartis AG, Kite Pharma (a Gilead Company), Medigene AG, and Sangamo Therapeutics.